AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

Every cell in the human body operates on an intricate internal schedule, governed by circadian rhythms that synchronize our ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a ...

T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

The effectiveness of daily low-dose aspirin in reducing cancer risk varied widely across the study cohort, indicating personalized treatment approaches would be beneficial. Clonal hematopoiesis of ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced new paradigm changing findings from the Phase 2 QUILT-3.055 study, ...

The researchers found that 5.6% of women developed a contralateral breast cancer, which was 3.1% more than expected, and that the absolute excess risk for contralateral breast cancer was greater in ...

Contralateral breast cancer drives overall increase, especially in younger women. HealthDay News — The risk for second primary cancers is higher for breast cancer survivors than for women in the ...

CLEVELAND, Ohio — A recent study led by Cleveland-area researchers suggests that prostate cancers classified as low risk may not be as low risk as previously thought. The study included researchers ...

Please provide your email address to receive an email when new articles are posted on . Counties with low cervical cancer screening rates had significantly higher incidence and mortality. Counties ...

Breast cancer is the most common malignant neoplasm among women, accounting for approximately 25% of new cancer cases and 15% of cancer deaths worldwide (1). In Brazil alone, an estimated 66,280 new ...